Miltenyi Biomedicine Gmbh

This pilot study is testing a new method for stem cell transplants in adults with high-risk blood cancers who don't have a perfectly matched donor. The method uses a specially processed graft from a half-matched (haploidentical) donor, aiming to reduce the risk of severe graft-ve…

This early-stage trial is testing a new treatment called MB-CART 2019.1 for people with multiple sclerosis (MS) that continues to get worse despite standard medications. The study will first check if the treatment is safe and find the right dose, then see if it can stop all signs…